Literature DB >> 15296470

Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study.

Elena Kamycheva1, Johan Sundsfjord, Rolf Jorde.   

Abstract

OBJECTIVE: To study whether serum parathyroid hormone (PTH) and serum calcium are associated with body mass index (BMI), and their predicting role in obesity.
DESIGN: Population based, cross-sectional study.
METHODS: In 2001 a population-based health survey was held in Tromsø, North Norway. Questionnaires on medical history and life-style factors were completed and anthropometric data were collected. Calcium and vitamin D intakes and a physical activity score were calculated. Serum calcium and PTH were measured in a subset of 3447 men and 4507 women. Pearson correlation and linear regression were used to evaluate associations between BMI, PTH and serum calcium, and logistic regression was used to test PTH and serum calcium as predictors of obesity and to calculate odds ratio. Relative risk was calculated using frequency tables.
RESULTS: For serum calcium and PTH there was a significant positive relation to BMI in both genders (P<0.001), which to our knowledge has not previously been reported on the basis of a large epidemiological study. Age, low calcium and vitamin D intakes were explanatory variables for serum PTH. The highest quartile of serum PTH (>4.20 pmol/l) was a significant predictor for obesity (P<0.001) in both genders, adjusted for age, physical activity and serum calcium. Obesity rates were higher in those with PTH levels in the highest quartile compared with those in the lower quartiles, which resulted in a relative risk of 1.40 (95% confidence interval (C.I.) 1.20-1.60) for men and 1.48 (95% C.I. 1.31-1.67) for women.
CONCLUSIONS: Serum PTH, adjusted for age, physical activity and serum calcium, is positively associated with BMI in both sexes, and serum PTH is an independent predictor of obesity in our statistical model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296470     DOI: 10.1530/eje.0.1510167

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  59 in total

1.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults.

Authors:  Bryan Kestenbaum; Ronit Katz; Ian de Boer; Andy Hoofnagle; Mark J Sarnak; Michael G Shlipak; Nancy S Jenny; David S Siscovick
Journal:  J Am Coll Cardiol       Date:  2011-09-27       Impact factor: 24.094

2.  Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study.

Authors:  Abigail B Shoben; Bryan Kestenbaum; Gregory Levin; Andrew N Hoofnagle; Bruce M Psaty; David S Siscovick; Ian H de Boer
Journal:  Am J Epidemiol       Date:  2011-11-23       Impact factor: 4.897

Review 3.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  An inverted U-shaped relationship between parathyroid hormone and body weight, body mass index, body fat.

Authors:  Tian-Jiao Yuan; Liu-Ping Chen; Ya-Ling Pan; Yong Lu; Li-Hao Sun; Hong-Yan Zhao; Wei-Qing Wang; Bei Tao; Jian-Min Liu
Journal:  Endocrine       Date:  2021-02-06       Impact factor: 3.633

5.  Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children.

Authors:  Claudia Boucher-Berry; Phyllis W Speiser; Dennis E Carey; Steven P Shelov; Siham Accacha; Ilene Fennoy; Robert Rapaport; Yomery Espinal; Michael Rosenbaum
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

6.  Causes of secondary hyperparathyroidism in a healthy population: the Tromsø study.

Authors:  Farahnaz Saleh; Rolf Jorde; Johan Sundsfjord; Egil Haug; Yngve Figenschau
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Vitamin D deficiency and calcium intake in reference to increased body mass index in children and adolescents.

Authors:  Sara Al-Musharaf; Abdulaziz Al-Othman; Nasser M Al-Daghri; Soundararajan Krishnaswamy; Deqa S Yusuf; Khalid M Alkharfy; Yousef Al-Saleh; Omar S Al-Attas; Majed S Alokail; Osama Moharram; Sobhy Yakout; Shaun Sabico; George P Chrousos
Journal:  Eur J Pediatr       Date:  2012-02-07       Impact factor: 3.183

8.  Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.

Authors:  D Han; S Trooskin; X Wang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

9.  The parathyroid leptin axis.

Authors:  Jaya George
Journal:  Endocrine       Date:  2017-04-28       Impact factor: 3.633

10.  Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey.

Authors:  Guler Tosunbayraktar; Murat Bas; Altug Kut; Aylin Hasbay Buyukkaragoz
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.